Edoxaban noninferior to warfarin for thromboembolism, bleeding early after surgical valve implantation or repair

In patients who underwent surgical bioprosthetic valve implantation or repair, early postoperative anticoagulation with edoxaban was noninferior to warfarin for preventing thromboembolism and major bleeding during the first 3 months after the procedure, according to results of the ENAVLE trial presented at the virtual American College of Cardiology Scientific Session. “Our findings suggest

Read the full article here

Related Articles